# Mendus - kliinisen vaiheen bioteknologiayritys

**URL:** https://forum.inderes.com/t/mendus-clinical-stage-biotechnology-company/52274
**Category:** Osakkeet
**Tags:** immun, mendus, ulkomaiset-osakkeet
**Created:** [Heinäkuu 23, 2024, 7.30pm UTC](https://forum.inderes.com/t/mendus-clinical-stage-biotechnology-company/52274 "2024-07-23T19:30:20Z")
**Posts on this page:** 1
**Showing post:** 3

<div class="post-metadata">

### Author: ![Sijoittaja-alokas](https://forum.inderes.com/user_avatar/forum.inderes.com/sijoittaja-alokas/32/74872_2.png) [@Sijoittaja-alokas](https://forum.inderes.com/u/Sijoittaja-alokas)
#### Post date: [Heinäkuu 24, 2024, 4.39am UTC](https://forum.inderes.com/t/mendus-clinical-stage-biotechnology-company/52274/3 "2024-07-24T04:39:27Z")

</div>

Tässä on **Antin** tuoreet kommentit Mendusin tuoreesta ilixadenceli-tutkimuksen yhteistyöstä. 🙂 💎

_Mendus [announced](https://www.inderes.fi/releases/mendus-announces-collaboration-with-institut-bergonie-to-study-ilixadencel-in-soft-tissue-sarcomas) on Tuesday that the company will start a new ilixadencel trial in collaboration with the French cancer center Institut Bergonié. The trial will combine ilixadencel with the cancer drugs regorafenib and avelumab for soft-tissue sarcomas (STS). According to the announcement, first patient data should be available in H1’26. The news merit minor adjustments in our estimates which we will implement with the Q2’24 pre-comment._

> **[Mendus brings ilixadencel back into clinical development - Inderes](https://www.inderes.fi/analyst-comments/mendus-brings-ilixadencel-back-into-clinical-development)**
>
> Mendus announced on Tuesday that the company will start a new ilixadencel trial in collaboration with the French cancer center Institut Bergonié. The trial will combine ilixadencel with the cancer drugs regorafenib and avelumab for soft-tissue...

---

_[View the full topic](https://forum.inderes.com/t/mendus-clinical-stage-biotechnology-company/52274)._
